282 related articles for article (PubMed ID: 32238586)
1. Beta Human Papillomavirus 8E6 Attenuates LATS Phosphorylation after Failed Cytokinesis.
Dacus D; Cotton C; McCallister TX; Wallace NA
J Virol; 2020 Jun; 94(12):. PubMed ID: 32238586
[TBL] [Abstract][Full Text] [Related]
2. β-HPV 8E6 combined with TERT expression promotes long-term proliferation and genome instability after cytokinesis failure.
Dacus D; Riforgiate E; Wallace NA
Virology; 2020 Oct; 549():32-38. PubMed ID: 32818730
[TBL] [Abstract][Full Text] [Related]
3. Beta human papillomavirus E6 expression inhibits stabilization of p53 and increases tolerance of genomic instability.
Wallace NA; Robinson K; Galloway DA
J Virol; 2014 Jun; 88(11):6112-27. PubMed ID: 24648447
[TBL] [Abstract][Full Text] [Related]
4. Beta Human Papillomavirus 8E6 Attenuates Non-Homologous End Joining by Hindering DNA-PKcs Activity.
Hu C; Bugbee T; Gamez M; Wallace NA
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825402
[TBL] [Abstract][Full Text] [Related]
5. The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.
Müller-Schiffmann A; Beckmann J; Steger G
J Virol; 2006 Sep; 80(17):8718-28. PubMed ID: 16912319
[TBL] [Abstract][Full Text] [Related]
6. HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage.
Wallace NA; Robinson K; Howie HL; Galloway DA
PLoS Pathog; 2012; 8(7):e1002807. PubMed ID: 22807682
[TBL] [Abstract][Full Text] [Related]
7. CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
Tian Y; Chen H; Qiao L; Zhang W; Zheng J; Zhao W; Chen JJ; Zhang W
J Cell Mol Med; 2018 Sep; 22(9):4150-4160. PubMed ID: 29893470
[TBL] [Abstract][Full Text] [Related]
8. Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association.
Howie HL; Koop JI; Weese J; Robinson K; Wipf G; Kim L; Galloway DA
PLoS Pathog; 2011 Aug; 7(8):e1002211. PubMed ID: 21901101
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis.
Muench P; Probst S; Schuetz J; Leiprecht N; Busch M; Wesselborg S; Stubenrauch F; Iftner T
Cancer Res; 2010 Sep; 70(17):6913-24. PubMed ID: 20663910
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation.
Giampieri S; García-Escudero R; Green J; Storey A
Oncogene; 2004 Jul; 23(34):5864-70. PubMed ID: 15077176
[TBL] [Abstract][Full Text] [Related]
11. β-HPV 5 and 8 E6 disrupt homology dependent double strand break repair by attenuating BRCA1 and BRCA2 expression and foci formation.
Wallace NA; Robinson K; Howie HL; Galloway DA
PLoS Pathog; 2015 Mar; 11(3):e1004687. PubMed ID: 25803638
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.
Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K
PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544
[TBL] [Abstract][Full Text] [Related]
13. Beta-Genus Human Papillomavirus 8 E6 Destabilizes the Host Genome by Promoting p300 Degradation.
Dacus D; Wallace NA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452526
[TBL] [Abstract][Full Text] [Related]
14. Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.
Hoppe-Seyler K; Bossler F; Lohrey C; Bulkescher J; Rösl F; Jansen L; Mayer A; Vaupel P; Dürst M; Hoppe-Seyler F
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E990-E998. PubMed ID: 28115701
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
[TBL] [Abstract][Full Text] [Related]
17. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
18. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
Liu Y; McKalip A; Herman B
J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
[TBL] [Abstract][Full Text] [Related]
20. Beta human papillomavirus 8 E6 allows colocalization of non-homologous end joining and homologous recombination repair factors.
Hu C; Bugbee T; Dacus D; Palinski R; Wallace N
PLoS Pathog; 2022 Feb; 18(2):e1010275. PubMed ID: 35148356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
